ASCO26: After ivonescimab stumble, rivals unveil their own bispecific data

LabiotechBlockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?

FierceBiotechLilly preps for ph. 2 launch after Verve gene editor cuts cholesterol on par with PCSK9 inhibitors

IlluminaIllumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential with a 33.82% ROE - DirectorsTalk Interviews

Cytiva (Google News)Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery - BioSpectrum Asia

QiagenQiagen N.V. stock (NL0012169213): Jefferies trims target while shares edge higher - AD HOC NEWS

MedtronicMedtronic Clinical Research Freshers Job 2026 – Apply for The Role - BioTecNika

Fritsch GmbHLaboratory Mills Market Growth Outlook to 2035: Automation and Nanomaterials Fuel Demand - News and Statistics - IndexBox

Mettler ToledoMettler-Toledo stock (US5926881054): laboratory specialist steadies after earnings-driven volatility - AD HOC NEWS

10x Genomics BlogIs 10x Genomics (TXG) Quietly Recasting Its Product-Led Story After a Mixed Q1 Beat? - simplywall.st

10x Genomics News10x Genomics Inc Class A Trade Ideas — LS:A2PPQJ - TradingView

Every GreenThe MLB standings are lying to you with a third of the season gone - FanSided